T. Tan

EMBIO trial study protocol: left gastric artery embolisation for weight loss in patients living with obesity with a BMI 35–50 kg/m2

T. Sasikaran, E. Bourmpaki, Ahmed Rashid Ahmed, 2023, BMJ Open.

GWAS of random glucose in 476,326 individuals provide insights into diabetes pathophysiology, complications and treatment stratification

Sara M. Willems, C. Gieger, U. Thorsteinsdóttir, 2023, Nature Genetics.

Targeting the incretin system in obesity and type 2 diabetes mellitus.

Bernard Khoo, T. Tan, Saleem Ansari, 2024, Nature reviews. Endocrinology.

Glucagon-based therapy for people with diabetes and obesity: What is the sweet spot?

T. Tan, E.R. McGlone, 2024, Peptides.

Determining the role of novel metabolic pathways in driving intracranial pressure reduction after weight loss

C. Winder, Z. Alimajstorovic, R. Ottridge, 2023, Brain communications.

Adaptive infusion of a glucagon‐like peptide‐1/glucagon receptor co‐agonist G3215, in adults with overweight or obesity: Results from a phase 1 randomized clinical trial

J. Minnion, K. Alexiadou, Sirazum Choudhury, 2024, Diabetes, obesity & metabolism.